British Journal of Haematology · 2008 · 73 citations · 24 references
MedicineHematologyOncologyCancer ImmunologyHematologic OncologyMolecular OncologyBone Marrow EvaluationCancer Survival AnalysisRelapsed DiseaseTherapy Response AssessmentBone Marrow AssessmentDisease Relapse PredictionMolecular Marker ProfilingMolecular RelapsePrognostic BiomarkersPrognostic ModelsRelapsed Acute Myeloid LeukemiaWt1 Gene Alterations
We hypothesized that Wilms tumour 1 gene (WT1) expression levels in acute myeloid leukaemia (AML) patients might have predictive value and reveal molecular relapse kinetics. WT1 level was determined at diagnosis, during therapy and post-therapy follow-up in 89 patients who reached first complete remission (CR1) (952 samples, median 8 samples/patient, range 2-38). CR1 bone marrow (BM) WT1 level above normal (based on 39 healthy donors) was an independent adverse prognostic factor regarding both disease-free survival [hazard ratio (HR) 4.46, P = 0.001] and overall survival (HR 2.62, P = 0.019). By grouping 34 BM and 99 peripheral blood (PB) complete remission samples in monthly intervals prior to clinical relapse, disease development was delineated and a simple mathematical model constructed, that allowed for the prediction of relapse detection rates (RDRs) as well as median times [t(m)s] from WT1 positivity to clinical relapse. BM sampling was required to obtain RDRs above 93% and t(m)s above 67 d. Acceptable RDRs and t(m)s (81% and 44 d, respectively) could be acquired by bimonthly PB sampling. In conclusion, CR1 WT1 expression is an independent prognostic factor in AML. According to our model, BM is superior for relapse prediction, but PB samples are useful when shorter sampling intervals are possible.
24
Emmanuel Beillard, Niels Pallisgaard, Vincent H. J. van der Velden et al. · Leukemia · 2003 · 884 citations
Kazushi Inoue, Haruo Sugiyama, Hiroyasu Ogawa et al. · Blood · 1994 · 575 citations · Full text
Medicine, Hematology, Oncology +16
Chromosomal banding patterns in acute nonlymphocytic leukemia
JD Rowley, D Potter · Blood · 1976 · 346 citations · Full text
Life Sciences, Genetics, Hematology +14